Toth Financial Advisory’s KalVista Pharmaceuticals KALV Stock Holding History

Toth Financial Advisory’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-100	Closed	-$2.01K	–	946
2026 Q1	$2.01K	Hold	100	–	–	﹤0.01%	720
2025 Q4	$1.61K	Hold	100	–	–	﹤0.01%	738
2025 Q3	$1.22K	Hold	100	–	–	﹤0.01%	736
2025 Q2	$1.13K	Buy	+100	New	+$1.22K	﹤0.01%	695

Other funds holding KALV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Toth Financial Advisory's KALV Position: Q2 2026 in Review

Toth Financial Advisory sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 100 shares — an estimated $2.01K sold.

Toth Financial Advisory first reported a position in KALV in Q2 2025 and held it in 4 quarters. The position peaked at $2.01K in Q1 2026. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

Toth Financial Advisory reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Toth Financial Advisory sold 100 KalVista Pharmaceuticals shares in Q2 2026, an estimated $2.01K.
Toth Financial Advisory first reported a position in KalVista Pharmaceuticals in Q2 2025 and held it in 4 quarters.
Toth Financial Advisory's KalVista Pharmaceuticals position peaked at $2.01K in Q1 2026.
1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on Toth Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.